株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

軽度乾癬:世界の治験レビュー

Mild Psoriasis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 318802
出版日 ページ情報 英文 69 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
軽度乾癬:世界の治験レビュー Mild Psoriasis Global Clinical Trials Review, H2, 2014
出版日: 2014年10月31日 ページ情報: 英文 69 Pages
概要

当レポートでは、軽度乾癬の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどを提供しています。

イントロダクション

  • 軽度乾癬
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:免疫疾患治療薬の治験における軽度乾癬の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:免疫疾患治療薬の治験における軽度乾癬の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数 軽度乾癬

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

軽度乾癬治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • F. Hoffmann-La Roche Ltd.
    • Delenex Therapeutics AG
    • Anacor Pharmaceuticals, Inc.
    • Curatio Healthcare Pvt Ltd
    • CREABILIS Therapeutics S.r.l.
    • Cadila Pharmaceuticals Ltd.
    • BioCis Pharma Oy
    • Basilea Pharmaceutica AG
    • Alnapharm GmbH & Co. KG
    • Alimentary Health Ltd.
  • 代表的な研究機関・病院の治験の概要
    • Dermatologikum Hamburg
    • University of the Punjab
    • APMC College of Pharmaceutical Education & Research
    • University of Tasmania
    • Isfahan University of Medical Sciences

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2399CTIDB

GlobalData's clinical trial report, "Mild Psoriasis Global Clinical Trials Review, H2, 2014" provides data on the Mild Psoriasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mild Psoriasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mild Psoriasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Mild Psoriasis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Mild Psoriasis to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Mild Psoriasis to Immunology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Mild Psoriasis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Mild Psoriasis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Delenex Therapeutics AG
      • Clinical Trial Overview of Delenex Therapeutics AG
      • Anacor Pharmaceuticals, Inc.
      • Clinical Trial Overview of Anacor Pharmaceuticals, Inc.
      • Curatio Healthcare Pvt Ltd
      • Clinical Trial Overview of Curatio Healthcare Pvt Ltd
      • CREABILIS Therapeutics S.r.l.
      • Clinical Trial Overview of CREABILIS Therapeutics S.r.l.
      • Cadila Pharmaceuticals Ltd.
      • Clinical Trial Overview of Cadila Pharmaceuticals Ltd.
      • BioCis Pharma Oy
      • Clinical Trial Overview of BioCis Pharma Oy
      • Basilea Pharmaceutica AG
      • Clinical Trial Overview of Basilea Pharmaceutica AG
      • Alnapharm GmbH & Co. KG
      • Clinical Trial Overview of Alnapharm GmbH & Co. KG
      • Alimentary Health Ltd.
      • Clinical Trial Overview of Alimentary Health Ltd.
    • Clinical Trial Overview of Top Institutes / Government
      • Dermatologikum Hamburg
      • Clinical Trial Overview of Dermatologikum Hamburg
      • University of the Punjab
      • Clinical Trial Overview of University of the Punjab
      • APMC College of Pharmaceutical Education & Research
      • Clinical Trial Overview of APMC College of Pharmaceutical Education & Research
      • University of Tasmania
      • Clinical Trial Overview of University of Tasmania
      • Isfahan University of Medical Sciences
      • Clinical Trial Overview of Isfahan University of Medical Sciences
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Mild Psoriasis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Mild Psoriasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Mild Psoriasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Mild Psoriasis to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Mild Psoriasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Mild Psoriasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Mild Psoriasis to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Mild Psoriasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Mild Psoriasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Mild Psoriasis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Mild Psoriasis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Mild Psoriasis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Mild Psoriasis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Mild Psoriasis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Mild Psoriasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Mild Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Delenex Therapeutics AG, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Anacor Pharmaceuticals, Inc., 2014*
  • Mild Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Curatio Healthcare Pvt Ltd, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by CREABILIS Therapeutics S.r.l., 2014*
  • Mild Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cadila Pharmaceuticals Ltd., 2014*
  • Mild Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCis Pharma Oy, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Basilea Pharmaceutica AG, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alnapharm GmbH & Co. KG, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alimentary Health Ltd., 2014*
  • Mild Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dermatologikum Hamburg, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of the Punjab, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by APMC College of Pharmaceutical Education & Research, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tasmania, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2014*

List of Figures

  • Mild Psoriasis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Mild Psoriasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Mild Psoriasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Mild Psoriasis to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Mild Psoriasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Mild Psoriasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Mild Psoriasis to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Mild Psoriasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Mild Psoriasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Mild Psoriasis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Mild Psoriasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Mild Psoriasis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Mild Psoriasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Mild Psoriasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top